secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001213900-26-014338
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma Holdings acquires topiroxostat nanoemulsion patent for $8.82M in stock
--------------------------------------------------------------------------------

- Transfer price of $8.82M paid in 12.6M restricted shares at $0.70/share; closing by Feb 20, 2026.
- Transferor Xiaoyun Chen to provide technical services including R&D and registration.
- Transferor also entitled to 3% of net profit from product after commercial launch.
- Patent covers Topiroxostat Nanoemulsion and method; patent expires July 2036.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/0001213900-26-014338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/ea0276369-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-014338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer